Patents in the public interest

Pharmaceutical and biotechnology industries welcome the court order issued by the UK High Court permitting Chiron Corporation to monopolize the manufacture and marketing of hepatitis C virus test kits. This move by the High Court affirms that public interest remains top priority while granting court orders that protect patent rights and patent monopolies. Despite the increased costs of patented products, patent laws support technical progress, research and invention and also protect public from patent abuse.